Christine J. Guico-Pabia - Oct 29, 2021 Form 4 Insider Report for Nabriva Therapeutics plc (NBRV)

Role
Chief Medical Officer
Signature
/s/ J. Christopher Naftzger, power of attorney
Stock symbol
NBRV
Transactions as of
Oct 29, 2021
Transactions value $
$0
Form type
4
Date filed
11/1/2021, 06:10 PM
Previous filing
Oct 7, 2021
Next filing
Feb 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBRV Share Option Award $0 +100K $0.00 100K Oct 29, 2021 Ordinary Shares 100K $1.15 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on October 29, 2021.
F2 The option will vest over a four-year period. Twenty-five percent (25%) of the option will vest on the one (1)-year anniversary of the date of grant, and the remaining seventy-five percent (75%) of the option will vest on an annual pro-rata basis over the remaining vesting period.